Ajanta Pharma ties up with Biocon to market semaglutide across 26 overseas markets
- Posted on December 24, 2025
- By Financial Express
- 5 Views
Ajanta Pharma ties up with Biocon to market semaglutide across 26 overseas markets
Under the agreement, Biocon will supply semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in three countries, the company said in a regulatory filing.
